European regulatory landscape: Demystifying new Qualified Person (QP) requirements for supplying medicine in the EU and UK


To ensure full compliance and timely and efficient batch release processes, drug sponsors pursuing clinical trials and commercialization in the EU and UK require a deep understanding of European GMP requirements and the roles and responsibilities of the EU and UK QPs in this new environment. This whitepaper provides critical direction and support on this topic.